drugset / Trial / NCT01113229

Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage

NCT01113229

RandomizedParallel-groupDouble-blindPrevention

Summary

To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks.

Timeline

Start
2010-03
Primary completion
2014-07
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Oral

Indications